We are live on ! Find out more
ORIA

Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA

Delisted

ORIA was delisted on the 28th of April, 2023.

Back to rankings

51 hedge funds and large institutions have $149M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 6

4% more capital invested

Capital invested by funds: $142M → $149M (+$6.21M)

2% less funds holding

Funds holding: 52 → 51 (-1)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

Holders
51
Holders Change
-1
Holders Change %
-1.92%
% of All Funds
0.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
6
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
+$3.81M
2
Jane Street
Jane Street
New York
+$3.69M
3
AC
Aristeia Capital
Connecticut
+$1.52M
4
FTCM
First Trust Capital Management
Illinois
+$901K
5
Millennium Management
Millennium Management
New York
+$675K

Top Sellers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
-$3.86M
2
UOC
UBS O'Connor
Illinois
-$2.34M
3
CCM
Context Capital Management
California
-$1.04M
4
CF
Cantor Fitzgerald
New York
-$999K
5
AFM
Anson Funds Management
Texas
-$738K
Name Holding Trade Value Shares
Change 		Change in
Stake
WRBC
26
W.R. Berkley Corp
Connecticut
$1.74M – – –
RCM
27
Rivernorth Capital Management
Florida
$1.73M – – –
SCM
28
Segantii Capital Management
Hong Kong
$1.51M – – –
PMAM
29
Picton Mahoney Asset Management
Ontario, Canada
$1.51M – – –
ACA
30
Arena Capital Advisors
California
$1.42M – – –
LP
31
LMR Partners
United Kingdom
$1.06M – – –
CH
32
CVI Holdings
Delaware
$1.02M -$4.15K -417 -0.4%
WAM
33
Weiss Asset Management
Massachusetts
$1.02M – – –
DCM
34
Dupont Capital Management
Delaware
$1.01M – – –
SSA
35
Schonfeld Strategic Advisors
New York
$978K – – –
DCM
36
DG Capital Management
New York
$972K +$16.8K +1,690 +2%
WA
37
Whitebox Advisors
Minnesota
$754K – – –
MMRF
38
Michelson Medical Research Foundation
California
$510K +$506K +50,780 New
COPPSERS
39
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$502K – – –
ETH
40
Exos TFP Holdings
New York
$432K -$1.35K -136 -0.3%
LA
41
Linden Advisors
New York
$420K – – –
Bank of Nova Scotia
42
Bank of Nova Scotia
Ontario, Canada
$404K – – –
VF
43
Virtu Financial
New York
$356K +$236K +23,748 +206%
HighTower Advisors
44
HighTower Advisors
Illinois
$278K -$3.86M -387,700 -93%
PAMP
45
Polar Asset Management Partners
Ontario, Canada
$270K – – –
WCMNY
46
Westchester Capital Management (New York)
New York
$251K +$249K +25,015 New
Susquehanna International Group
47
Susquehanna International Group
Pennsylvania
$215K +$213K +21,363 New
HF
48
HRT Financial
New York
$201K +$2.09K +210 +1%
CC
49
Centiva Capital
New York
$106K – – –
UBS Group
50
UBS Group
Switzerland
$131 – – –
1
2
3

ORIA Hedge Fund Activity: Q4 2022 in Review

51 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q4 2022, worth a combined $149M — up 4.4% from $142M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ORIA and 5 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 11 added.

The largest buyer was Glazer Capital LLC, adding an estimated $3.81M. The largest seller was HighTower Advisors, cutting an estimated $3.86M.

  • 51 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q4 2022, down from 52 in Q3 2022.
  • Funds reported $149M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q4 2022, up 4.4% quarter-over-quarter.
  • 5 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q4 2022 and 6 closed out, a net change of -1 holder.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q4 2022 was Glazer Capital LLC, an estimated $3.81M added.
  • The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q4 2022 was HighTower Advisors, an estimated $3.86M sold.

Based on aggregated 13F filings for Q4 2022.